PIA
LJPC

Powell Investment Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Powell Investment Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,000
Closed -$48K – 123
2020
Q3 		$48K Buy
+12,000
New +$49.7K 0.04% 104

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Powell Investment Advisors's LJPC Position: Q4 2020 in Review

Powell Investment Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2020, closing a stake of 12,000 shares — an estimated $48K sold.

Powell Investment Advisors first reported a position in LJPC in Q3 2020 and held it in 1 quarter. The position peaked at $48K in Q3 2020. 65 funds tracked by Wall St. Rank hold LJPC as of Q4 2020.

  • Powell Investment Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q4 2020 after selling out during the quarter.
  • Powell Investment Advisors sold 12,000 La Jolla Pharmaceutical Company shares in Q4 2020, an estimated $48K.
  • Powell Investment Advisors first reported a position in La Jolla Pharmaceutical Company in Q3 2020 and held it in 1 quarter.
  • Powell Investment Advisors's La Jolla Pharmaceutical Company position peaked at $48K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2020.

Based on Powell Investment Advisors's 13F filing for Q4 2020, filed 14 Jan 2021.